BAAM
MLAB icon

Baker Avenue Asset Management’s Mesa Laboratories MLAB Stock Holding History

Baker Avenue Asset Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$257 – 1665
2023
Q2 		$257 Buy
+2
New +$305 ﹤0.01% 1538

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Baker Avenue Asset Management's MLAB Position: Q3 2023 in Review

Baker Avenue Asset Management sold out of Mesa Laboratories (MLAB) in Q3 2023, closing a stake of 2 shares — an estimated $257 sold.

Baker Avenue Asset Management first reported a position in MLAB in Q2 2023 and held it in 1 quarter. The position peaked at $257 in Q2 2023. 154 funds tracked by Wall St. Rank hold MLAB as of Q3 2023.

  • Baker Avenue Asset Management reported no remaining Mesa Laboratories position as of Q3 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 2 Mesa Laboratories shares in Q3 2023, an estimated $257.
  • Baker Avenue Asset Management first reported a position in Mesa Laboratories in Q2 2023 and held it in 1 quarter.
  • Baker Avenue Asset Management's Mesa Laboratories position peaked at $257 in Q2 2023.
  • 154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2023.

Based on Baker Avenue Asset Management's 13F filing for Q3 2023, filed 15 Nov 2023.